Biggest News Aggregation in the World
📰 Operating Cost News

Page 12 - Operating Cost News Today

Fast, Ad-Free News Updates

Stay updated with breaking news from Operating Cost. Real-time updates on events, politics, business and more.

Alimera Sciences (NASDAQ:ALIM) Now Covered by Analysts at StockNews.com

StockNews.com initiated coverage on shares of Alimera Sciences (NASDAQ:ALIM – Free Report) in a report issued on Sunday. The firm issued a hold rating on the biopharmaceutical company’s stock. ALIM has been the subject of several other research reports. Alliance Global Partners raised shares of Alimera Sciences from a neutral rating to a buy rating […]
United States Craig Hallum Adam Morgan Securities Exchange Commission Renaissance Technologies News Ratings For Alimera Sciences Daily

Alimera Sciences (NASDAQ:ALIM) Now Covered by StockNews.com

Analysts at StockNews.com started coverage on shares of Alimera Sciences (NASDAQ:ALIM – Get Rating) in a research note issued on Sunday. The firm set a “hold” rating on the biopharmaceutical company’s stock. A number of other research firms also recently commented on ALIM. Alliance Global Partners raised shares of Alimera Sciences from a “neutral” rating […]
United States Craig Hallum Adam Morgan Renaissance Technologies Alimera Sciences Inc Susquehanna International Group

Karyopharm Therapeutics (NASDAQ:KPTI) & Alimera Sciences (NASDAQ:ALIM) Critical Survey

Karyopharm Therapeutics (NASDAQ:KPTI – Get Rating) and Alimera Sciences (NASDAQ:ALIM – Get Rating) are both small-cap medical companies, but which is the better business? We will compare the two companies based on the strength of their risk, valuation, institutional ownership, earnings, analyst recommendations, dividends and profitability. Valuation and Earnings This table compares Karyopharm Therapeutics and […]
United States Selective Inhibitor Of Nuclear Export Alimera Sciences Therapeutics Inc Antengene Therapeutics Menarini Group
Source: wkrb13.com

Stay Updated with Latest News

Get breaking news updates delivered to your inbox

Browse All News →

StockNews.com Initiates Coverage on Alimera Sciences (NASDAQ:ALIM)

StockNews.com started coverage on shares of Alimera Sciences (NASDAQ:ALIM – Get Rating) in a report released on Saturday morning. The brokerage issued a hold rating on the biopharmaceutical company’s stock. Other equities research analysts have also recently issued research reports about the stock. Craig Hallum decreased their target price on shares of Alimera Sciences from […]
United States Craig Hallum Adam Morgan Millennium Management Insider Activity At Alimera Sciences Institutional Trading Of Alimera Sciences

Alimera Sciences (NASDAQ:ALIM) Coverage Initiated at StockNews.com

StockNews.com assumed coverage on shares of Alimera Sciences (NASDAQ:ALIM – Get Rating) in a report published on Saturday. The firm issued a hold rating on the biopharmaceutical company’s stock. A number of other brokerages have also commented on ALIM. Alliance Global Partners upgraded shares of Alimera Sciences from a neutral rating to a buy rating […]
United States Adam Morgan Craig Hallum Insider Transactions At Alimera Sciences Securities Exchange Commission Renaissance Technologies

Euronav (NYSE:EURN) Downgraded by StockNews.com to "Hold"

Alimera Sciences (NASDAQ:ALIM – Get Rating) was upgraded by equities research analysts at Alliance Global Partners from a “neutral” rating to a “buy” rating in a note issued to investors on Monday, The Fly reports. Other research analysts also recently issued research reports about the company. HC Wainwright cut their target price on Alimera Sciences […]
United States Craig Hallum Adam Morgan Alimera Sciences Company Profile Alimera Sciences Trading Susquehanna International Group

Alimera Sciences, Inc. (NASDAQ:ALIM) Short Interest Up 3,157.6% in May

Alimera Sciences, Inc. (NASDAQ:ALIM – Get Rating) was the recipient of a significant growth in short interest during the month of May. As of May 31st, there was short interest totalling 791,600 shares, a growth of 3,157.6% from the May 15th total of 24,300 shares. Based on an average daily trading volume, of 606,100 shares, […]
United States Adam Morgan Craig Hallum Institutional Investors Weigh In On Alimera Sciences Millennium Management Securities Exchange Commission

Alimera Sciences (NASDAQ:ALIM) Upgraded to "Buy" at Alliance Global Partners

Alliance Global Partners upgraded shares of Alimera Sciences (NASDAQ:ALIM – Get Rating) from a neutral rating to a buy rating in a research report report published on Monday, The Fly reports. A number of other research firms have also issued reports on ALIM. Craig Hallum reduced their target price on shares of Alimera Sciences from […]
United States Craig Hallum Adam Morgan Renaissance Technologies Alimera Sciences Inc Alimera Sciences Trading

Explore More Categories

World News India News Business Technology Sports Entertainment Health Science